Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMolecular ImagingPET/CT scans show lung damage in stone workersThe metabolic activities occurring in the lungs of these patients have been unknown.CTSCCT: Study explores diagnostic accuracy of CCTACTSCCT: AI predicts coronary artery calcium scores from chest x-raysCTSCCT: CCTA model shows plaque volume changes in chest pain patientsSponsor ContentYou think ahead. We innovate ahead.
